Home > Drug Search >
  • company_query: AMAG Pharmaceuticals
  •   > 
Drug Filter
Category:
chemistry (23) biology (7)
Status:
Approved (1) Withdrawn (2) Phase Ⅲ (4) Phase Ⅱ (11) Phase Ⅰ (11) IND Filing (1)
Clinical Stage:
Pending (4) Active (13) Discontinued (10)
Bio-Type:
Vaccine (4) Blood extraction (1) Animal extract (1) ADC (1)
Indication:
Non-alcoholic steatohepatitis (2) Acne (1) Breast cancer (1) Cancer chemotherapy (1) Cognitive disorders (1) Contrast agents (2) Iron-deficiency anemia (1) Endometriosis (1) Anal cancer (1) Alcoholic hepatitis (1) Hypertension (1) Inflammatory bowel disease (1) Lymphoma (1) Multiple sclerosis (MS) (1) Myocardial infarction (MI) (1) Obesity (1) Fatty liver (1) Osteosarcoma (1) Overactive bladder (OAB) (1) Peripheral arterial disease (PAD) (1) Prostate cancer (2) Psoriasis (2) Pulmonary arterial hypertension (1) Rheumatoid arthritis (RA) (1) Oropharyngeal cancer (1) Solid tumours (2) Tinnitus (1) Type 2 diabetes (4) Head and neck cancer (1) Metastatic non-small cell lung cancer (1) Autistic disorder (1) Cervical carcinoma (1) Diagnostic agents (1) Type 1 diabetes (1) Hematological cancer (1) Glioblastoma (1) Graft versus host disease (1) Ischemia-reperfusion injury (1) Diabetic retinopathy (1) Acute kidney injury (1) Meniere's disease (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top